Inzinzac Lochrist, France
- Featured
TemPo Studies
**All eligible study participants will receive at no cost:** • Study-related consultation and care • Study visits, tests, assessments, and procedures • Study drugs (investigational drug or placebo)
Phase
N/ASpan
212 weeksSponsor
Cerevel TherapeuticsNîmes cedex, France
Recruiting
- Featured
Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery
Phase
N/ASpan
135 weeksSponsor
Centre Hospitalier Universitaire de NīmesNimes
Recruiting
Evaluation of Perineural Catheterization Practices in Postoperative Orthopedic Surgery
Phase
N/ASpan
82 weeksSponsor
Centre Hospitalier Universitaire de NīmesNimes
Recruiting
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
Phase
N/ASpan
157 weeksSponsor
Centre Hospitalier Universitaire de NīmesNimes
Recruiting
Immunological Reaction of the Recipient After Cold-stored Saphenous Venous Allograft (Bioprotec)
Phase
N/ASpan
186 weeksSponsor
Centre Hospitalier Universitaire de NīmesNimes
Recruiting
Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population
Phase
N/ASpan
105 weeksSponsor
WicabNimes
Recruiting
Healthy Volunteers
Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)
Phase
2Span
209 weeksSponsor
Assistance Publique - Hôpitaux de ParisNimes
Recruiting
Effect of Lumbar Surgery on Complexity During a Walking Task in Chronic Low Back Pain
Phase
N/ASpan
185 weeksSponsor
Centre Hospitalier Universitaire de NīmesNimes
Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
Phase
1/2Span
304 weeksSponsor
Bristol-Myers SquibbNimes
Recruiting
1-10 of 60